海王生物：关于对外担保进展暨解除对外担保的公告

Core Viewpoint - The company announced the approval of a proposal regarding the continuation of external guarantees, which was passed in meetings held on August 14, 2025, and October 24, 2025 [1] Group 1 - The company's subsidiary, Guangdong Haiwang Pharmaceutical Group Co., Ltd., signed a share transfer agreement with Guangxi Haixing Pharmaceutical Co., Ltd. due to issues related to credit approval, resulting in the company providing a credit guarantee [1] - The company has fully released its guarantee obligations towards Guangxi Haixing, and there are no longer any forms of guarantee for its debts [1]